The impact of combined inhaled bronchodilator therapy in the treatment of COPD

Chest

Volumn 119, Issue 1, 2001, Pages 85-92

  Benayoun, S ^a   Pharm, B ^a   Ernst, P ^a   Suissa, S ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Bronchodilator agents; Databases; Economies; Obstructive lung diseases

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST CONTROL; DATA BASE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0035125812     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.1.85     Document Type: Article

References (21)

1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
2. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial
3. Effective site of bronchodilation by β-adrenergic and anticholinergic agents in patients with chronic obstructive pulmonary disease: Direct measurement of intrabronchial pressure with a new catheter
4. The background to Duovent
5. Multiple dose regimens: Impact on compliance
6. Health promotion and maintenance for patients with chronic obstructive pulmonary disease: A review
7. Medication adherence patterns in chronic obstructive pulmonary disease
8. Patient compliance: Are we wasting our time and don't know it?
9. Saskatchewan health data bases: A developing resource
10. Health databases in Saskatchewan
11. Aspects of the validity of the Saskatchewan Administrative Health Care Utilization data files
12. Ipratropium bromide: A review of its pharmacologic properties and therapeutic efficacy in asthma and chronic bronchitis
13. BTS guidelines for the management of chronic obstructive pulmonary disease
14. Guidelines on the management of asthma
15. Canadian asthma consensus conference summary of recommendations
16. A community-based study of the epidemiology of asthma: Incidences rates, 1964-1983
17. The need for randomization in the study of intended effects
18. Postmarketing studies of drug efficacy: When must they be randomized?
19. Precision and validity in epidemiologic studies